QIAGEN IBERIA, S.L. secures contract for Blood-testing reagents - Supply of Kits for the quantitative monitoring of genetic alterations of hematological neoplasms of the myeloid line in the Hematology Laboratory of the Catalan Institute of Oncology

Spain, Oct. 21 -- Spain based QIAGEN IBERIA, S.L. has secured contract from Institut Catala d'Oncologia (ICO) for Blood-testing reagents - Supply of Kits for the quantitative monitoring of genetic alterations of hematological neoplasms of the myeloid line in the Hematology Laboratory of the Catalan Institute of Oncology. The value of the contract is 216350 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....